317 studies found for:    HIV [CONDITION] AND ((anti-hiv OR antiretroviral) AND medicines) [TREATMENT] | Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
HIV [CONDITION] AND ((anti-hiv OR antiretroviral) AND medicines) [TREATMENT] | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure
Condition: HIV Infection
Interventions: Drug: dolutegravir;   Drug: lamivudine;   Drug: Continue current antiretroviral regimen
2 Recruiting Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
Condition: HIV Infections
Interventions: Drug: atazanavir/cobicistat;   Drug: darunavir/ritonavir;   Drug: darunavir/cobicistat;   Drug: etravirine;   Drug: elvitegravir/cobicistat;   Drug: dolutegravir;   Drug: tenofovir alafenamide fumarate (TAF);   Drug: TAF/cobicistat;   Drug: TAF/ritonavir;   Drug: efavirenz;   Drug: lopinavir/ritonavir;   Drug: nevirapine;   Drug: rifampicin;   Drug: ethambutol;   Drug: isoniazid;   Drug: pyrazinamide;   Drug: kanamycin;   Drug: amikacin;   Drug: capreomycin;   Drug: moxifloxacin;   Drug: levofloxacin;   Drug: ofloxacin;   Drug: ethionamide/prothionamide;   Drug: terizidone/cycloserine;   Drug: para-aminosalicylic acid (PAS);   Drug: high dose isoniazid (INH);   Drug: bedaquiline;   Drug: clofazamine;   Drug: delamanid;   Drug: linezolid;   Drug: pretomanid;   Drug: atazanavir/ritonavir/tenofovir;   Drug: ethinyl estradiol oral contraceptive;   Drug: etonogestrel implant
3 Unknown  Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring
Conditions: Human Immunodeficiency Virus;   HIV Infections
Interventions: Drug: Reducing dose of Lopinavir;   Drug: Reducing dose of efavirenz
4 Unknown  Improving Antiretroviral Medication Adherence Among HIV-infected Youth
Condition: HIV Infection
Intervention: Behavioral: Positive STEPS
5 Recruiting Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Any Antiretroviral Therapy
6 Unknown  A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance
Conditions: HIV;   HIV Infections
Intervention: Drug: Raltegravir
7 Unknown  Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients
Conditions: Acquired Immune Deficiency Syndrome;   HIV Infections
Interventions: Drug: first line ARV (3TC+NVP+D4T or 3TC+NVP+AZT);   Drug: second line ARV therapy (3TC+TDF+LPV/RTV)
8 Unknown  Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV
Condition: HIV Infections
Interventions: Drug: Lopinavir/Ritonavir;   Drug: Emtricitabine;   Drug: Stavudine
9 Recruiting Safety and Efficacy of Emtricitabine/Tenofovir Alafenamide as Part of Salvage Antiretroviral Regimens in Patients With Uncontrolled Viremia and Drug-Resistant HIV Infection
Conditions: HIV;   HBV
Intervention: Drug: Emtricitabine 200mg/tenofovir alafenamide 25 mg (F/TAF)
10 Unknown  Raltegravir in the Swiss HIV Cohort Study
Condition: HIV Infection
Intervention: Drug: Raltegravir
11 Not yet recruiting The Lymphoid Tissue Pharmacology of Antiretroviral Drugs
Condition: HIV Infection
Intervention: Drug: Anti-HIV Agents
12 Recruiting Latency and Early Neonatal Provision of Antiretroviral Drugs Clinical Trial
Condition: HIV
Interventions: Drug: Nevirapine (NVP);   Drug: Zidovudine (ZDV);   Drug: Lamivudine (3TC)
13 Recruiting CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)
Condition: HIV, Inflammation
Interventions: Drug: Assess Safety;   Drug: Effect of drug on viral load;   Drug: Effect of drug on T-cell count;   Drug: Effect of drug on inflammatory biomarkers
14 Recruiting Interaction With HIV Antiretroviral Agents
Condition: HIV-DDI
Interventions: Drug: Riociguat (ADEMPAS);   Drug: ATRIPLA;   Drug: COMPLERA;   Drug: STRIBILD;   Drug: TRIUMEQ;   Drug: Antiretroviral protease inhibitor
15 Unknown  Once Daily 3TC, Efavirenz and ddI for HIV Infection
Conditions: HIV Infection;   AIDS
Intervention: Drug: once daily minimum 3-drug regimen of anti-retroviral medications
16 Recruiting Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Condition: HIV Infections
Interventions: Drug: Lamivudine/zidovudine;   Drug: Efavirenz;   Drug: Raltegravir
17 Recruiting A Trial of Observed Long-acting, Anti-HIV Treatment With a Monoclonal CCR5 Antibody (PRO 140) as an Adjunct to a New, Optimized, Oral Antiretroviral Regimen in HIV-infected Injection Drug Users With Viral Rebound and Documented Poor Adherence
Condition: HIV
Interventions: Drug: PRO 140;   Drug: Placebo
18 Not yet recruiting Triumeq As an Integrase Single Tablet Regimen in People With HIV Who Inject Drugs
Condition: Human Immunodeficiency Virus
Intervention: Drug: dolutegravir/abacavir/lamivudine
19 Recruiting PrEP Demonstration Project (PRELUDE Study)
Condition: HIV
Intervention: Drug: emtricitabine/tenofovir disoproxil fumarate
20 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: Nucleoside Reverse Transcriptase Inhibitors;   Drug: PEG-IFNa 2a;   Drug: Ribavirin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years